MedPath
NMPA Approval

Lopinavir/Ritonavir Oral Solution

国药准字HJ20130773

June 7, 2023

H20130773

Drug Information

洛匹那韦/利托那韦口服溶液

克力芝

口服溶液剂

每毫升口服液含洛匹那韦80mg,利托那韦20mg

化学药品

June 7, 2023

June 6, 2028

Company Information

Applicant Company

AbbVie, Inc.

1N Waukegan Rd, North Chicago, IL 60064, USA

Manufacturing Company

AbbVie, Inc.

1N Waukegan Rd, North Chicago, IL 60064, USA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

洛匹那韦/利托那韦口服溶液 - NMPA 批准文号 | MedPath